Don’t Take Chances: Why Doxycycline is a Great Bet Against STIs
A short course of antibiotics, Doxy-PEP, can prevent some STIs after condomless sex.
University of California San Francisco
Give to UCSF
The Truth About Dietary Supplements
Drawing on her decades of research and clinical experience, Mahtab Jafari, PharmD ’94, a professor of pharmaceutical sciences at UC Irvine, sheds light on the largely unregulated supplement industry and empowers readers to make choices informed by science.
Calling All Scientists to Fight the Next Pandemic
UCSF’s Nevan Krogan, PhD, is taking aim at the world’s deadliest diseases by uniting scientists and the biomedical industry to speed treatments.
Can this Medication Reverse MS? Brain Biomarker Shows It Can
UCSF researchers developed an approach to measure an over-the-counter allergy medication’s effectiveness in repairing brain damage from multiple sclerosis (MS), making it possible to also assess future therapies for the disorder.
Psychedelic Inspires New Treatments for Addiction and Depression
A traditional African psychedelic plant medicine called ibogaine is the blueprint for two new drug candidates that could treat addiction and depression.
UCSF is First in California to Provide Drug-Gene Testing
UCSF is the first hospital in California to offer pharmacogenetic testing for smarter prescribing. Testing identifies genetic makeup and tailors medications to improve efficacy and avoid lethal drug reactions.
Remembering Henry Bourne (1940-2023)
Henry Bourne, MD, a long-time UCSF researcher who chronicled its rise to prominence in the 1970s, has died at the age of 83.
Doxycycline for STI Prevention: Highly Effective, Minimal Drug Resistance
A sexual health strategy called Doxy-PEP, which involves taking doxycycline after condomless sex, is highly effective in reducing bacterial STIs but is still associated with a limited rise in resistant strains of bacteria.
An Allergy Drug Showed Promise for MS. Could They Prove It?
Proof of an over-the-counter allergy drug’s ability to reverse progression of multiple sclerosis provides monumental change for MS patients.
Can a Leading Laboratory Unlock the Cause of Gastrointestinal Disease?
Faranak Fattahi’s lab is a national leader in growing stem cells to model peripheral nerves, focusing on gastrointestinal diseases.
